Sopharma AD-SofiaWAR:SPH 68 Market Cap is zł4,374 Mil as of Jun. 28, 2026. GuruFocus rates WAR:SPH with a GF Score™ of 68/100 and a GF Value™ of zł12.97 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 120 Medical Distribution companies, Sopharma AD-Sofia ranks better than 76.67% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sopharma AD-Sofia's share price for the quarter that ended in Mar. 2026 was zł7.5. Sopharma AD-Sofia's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 528 Mil. Therefore, Sopharma AD-Sofia's market cap for the quarter that ended in Mar. 2026 was zł3,963 Mil.
Sopharma AD-Sofia's quarterly market cap
increased
from Sep. 2025 (zł6,621 Mil) to Dec. 2025 (zł6,701 Mil) but then
declined
from Dec. 2025 (zł6,701 Mil) to Mar. 2026 (zł3,963 Mil).
Sopharma AD-Sofia's annual market cap
declined
from Dec. 2023 (zł2,231 Mil) to Dec. 2024 (zł2,030 Mil) but then
increased
from Dec. 2024 (zł2,030 Mil) to Dec. 2025 (zł6,701 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sopharma AD-Sofia's Enterprise Value for Today is zł5,633 Mil.
Sopharma AD-Sofia (WAR:SPH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sopharma AD-Sofia Market Cap Related Terms
Sopharma AD-Sofia Market Cap Historical Data
* Premium members only.
The historical data trend for Sopharma AD-Sofia's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Sopharma AD-Sofia's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sopharma AD-Sofia Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's Market Cap distribution charts can be found below:
* The bar in red indicates where Sopharma AD-Sofia's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sopharma AD-Sofia's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sopharma AD-Sofia (WAR:SPH) has a Market Cap of zł4,374 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sopharma AD-Sofia and its competitors. According to the industry distribution chart, Sopharma AD-Sofia ranks #28 out of 120 companies in the Medical Distribution industry, placing it in the top 23.3%.
Is Sopharma AD-Sofia's Market Cap too high?
Sopharma AD-Sofia's current Market Cap is zł4,374 Mil. Based on the distribution chart, Sopharma AD-Sofia ranks #28 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Sopharma AD-Sofia has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sopharma AD-Sofia's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Sopharma AD-Sofia ranks #28 out of 120 companies for Market Cap. This places Sopharma AD-Sofia in the top 23% of its industry — outperforming the majority of peers. The industry median Market Cap is 144.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 144.29, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Sopharma AD-Sofia and its competitors. For the Medical Distribution industry, the median Market Cap is 144.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sopharma AD-Sofia's current Market Cap is zł4,374 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sopharma AD-Sofia stock overvalued right now?
Based on GuruFocus' analysis, Sopharma AD-Sofia (WAR:SPH) is currently considered Possible Value Trap. The stock's GF Value™ is zł12.97, compared to a current price of zł7.92 — trading 38.9% below its estimated fair value. The current Market Cap is zł4,374 Mil. Sopharma AD-Sofia's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Sopharma AD-Sofia (WAR:SPH), the current Market Cap is zł4,374 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sopharma AD-Sofia (WAR:SPH) Overvalued in 2026?
Based on GuruFocus' analysis, Sopharma AD-Sofia stock appears to be undervalued.
The current stock price of zł7.92 is trading 38.9% below its estimated GF Value™ of zł12.97.
GuruFocus considers Sopharma AD-Sofia to be Possible Value Trap.
Key valuation signals for WAR:SPH:
Market Cap: zł4,374 Mil
GF Value™: zł12.97 vs. price of zł7.92 (38.9% below fair value)
No single metric tells the full story. See the WAR:SPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products. It generates the majority of its revenue from the Distribution of pharmaceutical products.
68GF Score
Get the complete analysis for WAR:SPH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:SPH has been successfully added to your 
